First AD

Second AD

Genitourinary Cancers

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

Contemporary Management of Metastatic Renal Cell Carcinoma

Peer Exchange

Tyrosine Kinase Inhibitors Used Alone or in Combination to Treat RCC

Pembrolizumab Plus Axitinib for Advanced RCC

Additive and Overlapping Adverse Effects of RCC Therapy

CheckMate 214 Trial for Newly Diagnosed Metastatic RCC

Cytoreductive Nephrectomy in Metastatic RCC

NCCN Guideline Changes for First- & Beyond-First-Line RCC Therapy

Role of Risk Stratification in Treatment Planning for mRCC

Patient-Reported Outcomes for RCC Treatment Therapies

Factors Influencing Choice of Sequential Therapy in RCC

Safety and Tolerability Influence the Use of TKIs in RCC

Third-Line Therapy and Beyond in Treating Metastatic RCC

Ongoing Clinical Trials for Metastatic RCC

NKTR-214 and COSMIC-313 for Previously Untreated RCC

Biomarkers: Guide to Clinical Decision Making to Treat mRCC

Advances and Challenges Faced in the Treatment of mRCC